Loading...
PFAS And Pathogen Regulations Will Support Long Term Upside Potential
AN
AnalystConsensusTarget
Not Invested
Based on Analyst Price Targets
Published
20 Jan 26
Views
13
20 Jan
US$3.33
AnalystConsensusTarget's Fair Value
US$7.00
52.4% undervalued intrinsic discount1Y
-17.0%7D
-7.2%1Y
-17.0%7D
-7.2%You can edit this narrative until Jan 21 7:05 AM. Then, changes will post as Updates.
Author's Valuation
US$752.4% undervalued intrinsic discount
AnalystConsensusTarget Fair Value